Revenio Group Oyj (STU:R0V) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


STU:R0V Revenio Group Oyj STU:R0V
76 GF Score
Price €12.62
GF Value €30.54
! 2 Warning Signs
View Full Analysis

What is Revenio Group Oyj Research & Development?

Revenio Group Oyj STU:R0V +0.48% 76 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates STU:R0V with a GF Score™ of 76/100 and a GF Value™ of €30.54. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Revenio Group Oyj's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Revenio Group Oyj  (STU:R0V) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Revenio Group Oyj Research & Development Related Terms

Revenio Group Oyj Research & Development Historical Data

* Premium members only.

The historical data trend for Revenio Group Oyj's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revenio Group Oyj Research & Development Chart

Revenio Group Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.57 3.20 2.85 2.68 2.03

Revenio Group Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:R0V
76GF Score
Revenio Group Oyj STU:R0V
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revenio Group Oyj Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Revenio Group Oyj (STU:R0V) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Revenio Group Oyj and its competitors.
Is Revenio Group Oyj's Research & Development too high?
Revenio Group Oyj's current Research & Development is €0.0 Mil. Overall, Revenio Group Oyj has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's Research & Development compare to ABT and SYK?
Revenio Group Oyj's Research & Development of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Revenio Group Oyj and its competitors. Revenio Group Oyj's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Revenio Group Oyj (STU:R0V) has a current Research & Development of €0.0 Mil. The stock's GF Value™ is €30.54, compared to a current price of €12.62 — trading 58.7% below its estimated fair value. The current Research & Development is €0.0 Mil. Revenio Group Oyj's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Revenio Group Oyj (STU:R0V), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revenio Group Oyj (STU:R0V) Overvalued in 2026?

Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued. The current stock price of €12.62 is trading 58.7% below its estimated GF Value™ of €30.54.

Key valuation signals for STU:R0V:

  • Research & Development: €0.0 Mil
  • GF Value™: €30.54 vs. price of €12.62 (58.7% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the STU:R0V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revenio Group Oyj Business Description

Address Harkahaankuja 7, Vantaa, FIN, 01730
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
76GF Score

Get the complete analysis for STU:R0V

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.62
Price
€30.54
GF Value